We are live on ! Find out more
CPRX icon

Catalyst Pharmaceutical
CPRX

16 hedge funds and large institutions have $5.01M invested in Catalyst Pharmaceutical in 2013 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
–
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$3.59M +$3.23M +4,034,207 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$494K +$445K +555,585 New
SC
3
Sophrosyne Capital
New York
$458K +$408K +510,000 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$147K +$132K +165,418 New
TCM
5
Tanaka Capital Management
New York
$107K +$118K +147,993 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$41K +$37.2K +46,438 New
Northern Trust
7
Northern Trust
Illinois
$38K +$34.3K +42,906 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$37K +$33.1K +41,332 New
Bank of America
9
Bank of America
North Carolina
$20K +$17.7K +22,112 New
U
10
UBS
Switzerland
$16K +$14.5K +18,138 New
Citadel Advisors
11
Citadel Advisors
Florida
$15K +$13.5K +16,861 New
CA
12
CapWealth Advisors
Tennessee
$12K +$10.4K +13,000 New
CS
13
Credit Suisse
Switzerland
$12K +$11.1K +13,899 New
GC
14
Guggenheim Capital
Illinois
$11K +$9.85K +12,304 New
Creative Planning
15
Creative Planning
Kansas
$8K +$7.57K +9,455 New
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$2K +$1.6K +2,000 New

CPRX Hedge Fund Activity: Q2 2013 in Review

16 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q2 2013, worth a combined $5.01M.

Buyers outnumbered sellers: 16 funds opened new CPRX positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.

  • 16 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.01M of Catalyst Pharmaceutical stock for Q2 2013.
  • 16 funds opened new Catalyst Pharmaceutical positions in Q2 2013 and 0 closed out, a net change of +16 holders.

Based on aggregated 13F filings for Q2 2013.